GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » REMSleep Holdings Inc (OTCPK:RMSL) » Definitions » 3-Year EPS without NRI Growth Rate

REMSleep Holdings (REMSleep Holdings) 3-Year EPS without NRI Growth Rate : 55.00% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is REMSleep Holdings 3-Year EPS without NRI Growth Rate?

REMSleep Holdings's EPS without NRI for the three months ended in Dec. 2023 was $-0.00.

During the past 3 years, the average EPS without NRI Growth Rate was 55.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 65.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 51.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of REMSleep Holdings was 93.90% per year. The lowest was -91.60% per year. And the median was 55.00% per year.


Competitive Comparison of REMSleep Holdings's 3-Year EPS without NRI Growth Rate

For the Medical Devices subindustry, REMSleep Holdings's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


REMSleep Holdings's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, REMSleep Holdings's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where REMSleep Holdings's 3-Year EPS without NRI Growth Rate falls into.



REMSleep Holdings 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


REMSleep Holdings  (OTCPK:RMSL) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


REMSleep Holdings 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of REMSleep Holdings's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


REMSleep Holdings (REMSleep Holdings) Business Description

Traded in Other Exchanges
N/A
Address
14175 ICOT Blvd, Suite 300, Clearwater, FL, USA, 33760
REMSleep Holdings Inc is focused on designing and manufacturing devices and products for the treatment of sleep apnea and other respiratory conditions. The company offers the product DeltaWave which is specifically designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Geographically, the business activity of the group functions through the region of the United States.
Executives
Russell Finlay Bird 10 percent owner, officer: President 722 50TH STREET, DES MOINES IA 50312
Tom J Wood director, officer: CEO 1170 CHERRYWOOD RD, WAYCROSS GA 31503
Thomas Brookes director, officer: VP & MD OF EKOM EYA MINE DIV. 1149 TOPSAIL ROAD, MOUNT PEARL A4 AIN 5G2
Matthew Sullivan director, officer: ASST. VP OF EKOM EYA MINE DIV. 1149 TOPSAIL ROAD, MOUNT PEARL A4 AIN5G2
David M Barnes officer: Chief Financial Officer 6800 JERICHO TURNPIKE, SUITE 208E, SYOSSET NY 11791
Walter Leslie Thistle director, other: Chairman of the Board 17 COLLINGWOOD CRESCENT, MOUNT PEARL A4 A1N5C6
Kat Exploration Inc. 10 percent owner 1149 TOPSAIL ROAD, MOUNT PEARL A4 A1N5G2
Ken Stead director, 10 percent owner, officer: CEO and President 15 BLADE CRESCENT, MOUNT PEARL A4 A1N 5L1
Ronald Davis officer: PRESIDENT 4412 8TH STREET SW, VERO BEACH FL 32968

REMSleep Holdings (REMSleep Holdings) Headlines

From GuruFocus

RemSleep Holdings Inc. Commences Trading on OTCQB

By PurpleRose PurpleRose 07-27-2022

REMSleep Holdings -- Time Line Update

By Marketwired Marketwired 11-19-2020

Condensation Testing Per ISO 18562-4:2017

By GuruFocusNews GuruFocusNews 01-05-2022

REMSleep 510K Submission

By Marketwired Marketwired 10-28-2021

REMSleep Patent Application

By GlobeNewswire GlobeNewswire 11-20-2020

REMSleep Patent Application

By Marketwired Marketwired 11-20-2020

Shareholder Update

By Marketwired Marketwired 11-19-2020